Skip to main content
. Author manuscript; available in PMC: 2016 Dec 8.
Published in final edited form as: J Clin Gastroenterol. 2013 Nov-Dec;47(10):e91–e95. doi: 10.1097/MCG.0b013e318294baa4

TABLE 3.

Study Participation [n (%)]

Academic Centers
Community Centers
(n = 1905) (n = 1165) P
Treatment phase
    Completed 1020 (54) 634 (54) 0.64
    Discontinued 885 (46) 531 (46) 0.64
        Because of treatment failure 520 (27) 310 (27) 0.68
        Because of adverse events 234 (12) 128 (11) 0.28
        Because the patient did not wish to continue 63 (3) 45 (4) 0.42
        Because of lost to follow-up 44 (2) 34 (3) 0.30
        Because of noncompliance with protocol 18 (1) 13 (1) 0.65
        Because of protocol ineligibility 4 (<1) 1 (0.1) 0.41
        Administrative 2 (<1) 0 0.27
24-wk follow-up phase
    Completed 1507 (79) 910 (78) 0.51
    Discontinued 166 (9) 103 (9) 0.90
        Because of lost to follow-up 101 (5) 62 (5) 0.98
        Because the patient did not wish to continue 54 (3) 34 (3) 0.89
        Because of noncompliance with protocol 5 (<1) 4 (<1) 0.69
        Because of adverse events 6 (<1) 3 (<1) 0.78
    Never entered follow-up phase 232 (12) 151 (13) 0.52